Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
2.
Front Surg ; 9: 978697, 2022.
Article in English | MEDLINE | ID: mdl-36003279

ABSTRACT

Introduction: Kashin-Beck Disease (KBD) is an endemic disease predominantly affecting joint and skeletal muscle, predisposing the articular cartilage to degeneration and necrosis. Currently,staged total hip arthroplasty is a common surgical method for advanced femoral head necrosis from KBD, but there are no reports in the literature on simultaneous bilateral total hip arthroplasty (SB-THA) for patients with KBD. Case presentation: A 42-year-old male from Shaanxi Province, an endemic area, had bilateral hip pain for 4 years, with hips inversion and a crossed gait. After preoperative preparation, a SB-THA was performed by a posterolateral approach. Postoperative medication and functional exercises were administered and the patient was followed up for at least 3 years after discharge. The patient's hip mobility, hip scores and quality of life scores were recorded in detail during the follow-up. Result: The patient stopped antibiotic treatment on the postoperative day-2, and all inflammatory indicators showed normal and started appropriate exercise, and the pain score decreased significantly. On the postoperative day-7, the patient had gradually adapted to various forms of rehabilitation exercises. He was discharged from the hospital on the postoperative day-10 and continued to be followed up. From the preoperative period to the last follow-up, the patient's bilateral hip mobility and functional scores improved significantly, and no adverse events such as hip pain, prosthesis loosening or dislocation were found at the last follow-up. Conclusion: The patient's performance was satisfactory both intraoperatively and in the early postoperative period, but the hip scores and quality of life scores began to plateau or even decline from the third year after surgery to the last follow-up, probably due to the influence of further damage to articular cartilage in other parts of the body.

3.
Cell Mol Biol (Noisy-le-grand) ; 68(11): 47-52, 2022 Nov 30.
Article in English | MEDLINE | ID: mdl-37114309

ABSTRACT

It was to investigate the predictive value of NGAL and Fetuin-A for 28-day mortality in patients with sepsis, and to construct a mortality risk prediction model. 120 patients admitted to The Affiliated Hospital of Xuzhou Medical University Hospital were grouped. Serum biochemical parameters were measured and scale scores were performed. The patient data were divided into a training set and test set in a ratio of 7:3, and the logistic regression model and random forest model were included to evaluate the 28-day mortality prediction efficacy of each index and model. The results showed that WBC, PLT, RBCV, and PLR decreased, SCr, Lac, PCT, D-dimer, NPR, NGAL, and Fetuin-A increased, APACHE II scale, SOFA scale, and OASIS scale scores increased in the death group (P < 0.05). SCr ≥ 408 µmol/L, Lac ≥ 2.3 mmol/L, PCT ≥ 30 ng/mL, D-dimer ≥ 2.33 mg/L, PLR ≥ 190, APACHE II ≥ 18 points, SOFA ≥ 2, OASIS ≥ 30, NGAL ≥ 352 mg/L, and Fetuin-A ≥ 0.32 g/L were found to be risk factors for 28-day death, while WBC ≥ 12 × 109/L, PLT ≥ 172 × 103/µL, and RBCV ≥ 30% were found to be protective factors for 28-day mortality. The predicted AUCs of APACHE II, SOFA, OASIS, NGAL, Fetuin-A, NGAL & Fetuin-A, logistic regression model, and random forest model were 0.80, 0.71, 0.77, 0.69, 0.86, 0.92, 0.83, and 0.81. NGAL combined with Fetuin-A has good prediction efficacy in 28-day mortality in septic patients.


Subject(s)
Sepsis , alpha-2-HS-Glycoprotein , Humans , Lipocalin-2 , ROC Curve , Sepsis/diagnosis , APACHE , Retrospective Studies
4.
ACS Appl Mater Interfaces ; 12(14): 16805-16814, 2020 Apr 08.
Article in English | MEDLINE | ID: mdl-32186174

ABSTRACT

Excellent comprehensive dielectric properties (including dielectric constant and loss) are essential for electromechanical transducers. This work introduced a bimodal network composite with poly(dimethyl siloxane) (PDMS) and delaminated Ti3C2Tx sheets (d-Ti3C2Tx) modified with hyperbranched polysiloxane (HPSi) (referred to as HPSi-d-Ti3C2Tx). Before the final cross-linking, HPSi-d-Ti3C2Tx, trapped with short-chain PDMS (CS-PDMS) and long-chain PDMS (CL-PDMS), was pre-reacted, which formed a distinct bimodal network structure. d-Ti3C2Tx/PDMS and HPSi-d-Ti3C2Tx/PDMS composites with different filler loadings were prepared, and their percolation thresholds (fc) were 1.32 and 1.43 vol %, respectively The dielectric constant of 1.40 vol % HPSi-d-Ti3C2Tx/PDMS is 23.7 at 102 Hz, which is 1.5 times that of 1.28 vol % d-Ti3C2Tx/PDMS and 8.5 times that of pure PDMS. Meanwhile, the dielectric loss of HPSi-d-Ti3C2Tx/PDMS composite is still relatively small (0.11 at 103 Hz). The origin of dielectric property optimization of the composite is attributed to the boundary capacitor model, the accumulated charges at the interfaces between the conductive filler and the insulating polymer matrix of the composite, and the distinct bimodal network structure.

5.
Article in Chinese | MEDLINE | ID: mdl-23257088

ABSTRACT

OBJECTIVE: To investigate the effect of fasudil on in vitro cultured cardiomyocytes (CMs) exposed to omethoate and its possible mechanism. METHODS: Cardiomyocytes were isolated from male SD rats and were then cultured in DMEM conventionally. The CMs were divided into different groups based on the doses of omethoate and fasudil in culture media. After 3, 6, 12, and 24 h of culture, the survival rate of CMs in each group was measured, the CMs in the medium-dose omethoate and medium-dose fasudil groups were subject to shortening amplitude measurement , and the content of lactate dehydrogenase (LDH) in culture media and expression of Bcl-2 and Bax in CMs were measured. RESULTS: Compared with the normal control group, each omethoate group showed significantly lower survival rate of CMs, which was negatively correlated with the dose of omethoate (P < 0.01). Compared with the normal control group, the medium-dose omethoate and medium-dose fasudil groups showed significantly decreased shortening amplitudes of CMs at all time points (P < 0.01), and the shortening amplitudes of CMs were significantly higher in the medium-dose fasudil group than in the medium-dose omethoate group after 12 h and 24 h of culture (P < 0.01). The LDH level was significantly higher in the medium-dose omethoate and medium-dose fasudil groups than in the normal control group, and the medium-dose fasudil group showed significantly lower LDH level than the medium-dose omethoate group (P < 0.01). Compared with those in the normal control group, the Bcl-2 expression in the medium-dose omethoate and medium-dose fasudil groups was decreased significantly, and the Bax expression in the medium-dose omethoate group was increased significantly (P < 0.01). Compared with the medium-dose omethoate group, the medium-dose fasudil group had significantly increased Bcl-2 expression and significantly decreased Bax expression (P < 0.01). CONCLUSION: Fasudil can inhibit the abnormal expression of apoptosis regulatory proteins (Bcl-2 and Bax) induced by omethoate, which might be one of the factors that reduce the toxic effect of omethoate on CMs.


Subject(s)
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives , Dimethoate/analogs & derivatives , Myocytes, Cardiac/drug effects , Pesticides/poisoning , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/pharmacology , Animals , Cells, Cultured , Dimethoate/toxicity , Male , Myocytes, Cardiac/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Rats, Sprague-Dawley , bcl-2-Associated X Protein/metabolism
6.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue ; 18(9): 558-61, 2006 Sep.
Article in Chinese | MEDLINE | ID: mdl-16959158

ABSTRACT

OBJECTIVE: To observe the effect of methylene blue (MB) on the changes in plasma nitric oxide (NO), tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and visceral pathologic changes in rabbits with traumatic shock. METHODS: Eighteen rabbits were randomly assigned into 3 groups (n=6): sham operation group, traumatic shock with normal saline (NS) resuscitation group (NS group), and traumatic shock with MB resuscitation group (MB group). In NS group and MB group, hemodynamics was monitored, and plasma contents of NO, TNF-alpha and IL-6 were determined before shock, after shock, after resuscitation, and 0.5, 2 and 4 hours after resuscitation. In sham operation control group, hemodynamics monitoring and plasma contents of NO, TNF-alpha and IL-6 were also determined. Tissue samples of the liver and intestine were obtained after experiments for microscopic examination. RESULTS: Compared with NS group, hemodynamics was stable in MB group. The levels of plasma NO in rabbits after traumatic shock were much higher than those of before shock. In NS group, the levels of plasma NO were progressively increased after resuscitation, reaching peak level at 0.5 hour after resuscitation, then decreased thereafter but still remaining higher than those of before shock. But in MB group, the levels of plasma NO after resuscitation were obviously decreased. In sham operation group, the levels of plasma NO showed no significant changes during the whole course. The levels of plasma TNF-alpha and IL-6 in rabbits after traumatic shock were much higher than those of before shock. But after intravenous administration of MB, the levels of plasma TNF-alpha and IL-6 after resuscitation showed no significant difference compared with the baseline levels. In sham operation group, the levels of plasma TNF-alpha and IL-6 showed no significant changes during the entire course. In NS group, the organs showed prominent pathologic changes. But in MB group, less pathologic changes in the organs were milder, and in sham operation group, there was no obvious pathologic changes in the organs. CONCLUSION: NO, TNF-alpha and IL-6 play important roles in the pathologic process of traumatic shock and the administration of MB after resuscitation can decrease the levels of plasma NO, TNF-alpha and IL-6, improve hemodynamics in traumatic shock, and protect the important organs.


Subject(s)
Methylene Blue/pharmacology , Shock, Traumatic/drug therapy , Animals , Female , Interleukin-6/blood , Intestines/pathology , Liver/pathology , Male , Nitric Oxide/blood , Rabbits , Random Allocation , Shock, Traumatic/blood , Shock, Traumatic/pathology , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...